|
NAA40 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.50000012411056E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.61540028418028E-10 |
| Normal-vs-Stage2 |
7.58050000000399E-05 |
| Normal-vs-Stage3 |
2.22789997561534E-09 |
| Normal-vs-Stage4 |
6.26059999999651E-05 |
| Stage1-vs-Stage2 |
6.167000E-01 |
| Stage1-vs-Stage3 |
6.457800E-01 |
| Stage1-vs-Stage4 |
2.404400E-01 |
| Stage2-vs-Stage3 |
4.407800E-01 |
| Stage2-vs-Stage4 |
6.861400E-01 |
| Stage3-vs-Stage4 |
1.622360E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.96570537625007E-11 |
| Normal-vs-AfricanAmerican |
4.802300E-03 |
| Normal-vs-Asian |
9.971000E-01 |
| Caucasian-vs-AfricanAmerican |
1.386210E-02 |
| Caucasian-vs-Asian |
6.361100E-04 |
| AfricanAmerican-vs-Asian |
1.927620E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.40929515121979E-11 |
| Normal-vs-Female |
5.43670000019425E-07 |
| Male-vs-Female |
1.163720E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.364050E-04 |
| Normal-vs-Age(41-60Yrs) |
3.23900000154254E-08 |
| Normal-vs-Age(61-80Yrs) |
2.71910050031465E-10 |
| Normal-vs-Age(81-100Yrs) |
3.280000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.584000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.969600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.478600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.963200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.673400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.323200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.458400E-02 |
| Normal-vs-Grade 2 |
1.22429955062842E-10 |
| Normal-vs-Grade 3 |
1.56820000318802E-08 |
| Normal-vs-Grade 4 |
3.9597999999974E-05 |
| Grade 1-vs-Grade 2 |
2.257400E-01 |
| Grade 1-vs-Grade 3 |
4.030800E-01 |
| Grade 1-vs-Grade 4 |
5.766200E-01 |
| Grade 2-vs-Grade 3 |
3.027600E-01 |
| Grade 2-vs-Grade 4 |
2.290000E-01 |
| Grade 3-vs-Grade 4 |
6.493800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.24498197809453E-12 |
| Normal-vs-ccB subtype |
1.11510000000425E-06 |
| ccA subtype-vs-ccB subtype |
8.622200E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.67409999979529E-07 |
| Normal-vs-N1 |
8.829500E-02 |
| N0-vs-N1 |
3.221800E-01 |
|
|
